Pretty interesting statement and 2010 guidance.....
1) The Company projects achievement of profitability during fiscal year 2010.
The press release doesn't elaborate on whether profitability will be achieved as a result of product sales, licensing/milestone payments, debt reduction from the 2008 financing agreement (see post below), or some combination of the above, but no matter how it is achieved it will certainly be a positive thing. One of things that has always been attractive about VODG is the ability of management to move the company forward while keeping expenses/dilution relatively contained.
2) Independent analyses by multiple outside laboratories have confirmed superior performance of Vitro’s stem cell growth medium when compared to existing commercial products. These improvements lead to greater recoveries of useful cells, critical parameters for efficiency and generation of clinically relevant research results by Vitro’s customers.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.